检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:陈科署 林俊英 陈加链 蔡文阳[1] CHEN Ke-shu;LIN Jun-ying;CHEN Jia-lian;CAI Wen-yang(Department of Critical Care Medicine,Chaozhou Central Hospital,Chaozhou,Guangdong Province,521000 China)
机构地区:[1]潮州市中心医院重症医学科
出 处:《中外医疗》2019年第31期70-72,共3页China & Foreign Medical Treatment
摘 要:目的分析比较连续性肾脏替代治疗(CRRT)脓毒症急性肾损伤病例过程中实施局部枸橼酸抗凝与全身肝素化抗凝的临床效果。方法回顾性分析该院2016年1月-2018年12月诊治的60例脓毒症急性肾损伤患者CRRT治疗过程中完整的临床资料,对照组病例在CRRT治疗期间采用的抗凝方法为全身肝素化抗凝,观察组患者是应用枸橼酸抗凝,病例数各为30例。比较两组病例治疗后凝血功能、肾功能及滤器使用寿命。结果两组病例的APTT和PT均升高,但对照组APTT(62.32±9.62)s、PT(22.84±1.12)s较观察组上升程度大,差异有统计学意义(t=5.184、8.056,P<0.05);两组病例的PLT均有一定程度降低,但对照组(95.84±11.12)×10^9/L较观察组下降程度大,差异有统计学意义(t=12.055,P<0.05);通过治疗,两组患者BUN和Scr水平值均降低,并且观察组降低水平治疗后BUN(11.58±2.57)μmol/L、Scr(212.23±51.97)μmol/L比对照组BUN(15.32±2.62)μmol/L、Scr(253.84±55.12)μmol/L明显,差异有统计学意义(t=5.182、9.359,P<0.05)。结论应用枸橼酸抗凝在脓毒症急性肾损伤病例CRRT治疗时的临床疗效优于全身肝素化抗凝效果,有助于患者肾功能的改善和滤器使用时间的延长。Objective To analyze the clinical effects of local citrate anticoagulation and systemic heparinized anticoagulation during continuous renal replacement therapy(CRRT) sepsis. Methods A retrospective analysis of the complete clinical data of 60 patients with acute renal injury with sepsis diagnosed in the hospital from January 2016 to December 2018, and anticoagulation during the treatment of CRRT in the control group. The method was systemic heparinized anticoagulation.The patients in the observation group were treated with citrate anticoagulation, and the number of cases was 30 cases. Coagulation function, renal function and filter life were compared between the two groups. Results The APTT and PT were increased in both groups, but the APTT(62.32±9.62) s and PT(22.84±1.12) s in the control group were significantly higher than those in the observation group, and the differences were statistically significant(t=5.184, 8.056, P<0.05);PLT of both groups decreased to some extent, but the control group(95.84 ±11.12) ×10^9/L was significantly lower than the observation group, and the difference was statistically significant(t=12.055, P<0.05). After treatment, the BUN and Scr levels of the two groups were decreased, and the BUN(11.58±2.57)μmol/L, Scr(212.23±51.97)μmol/L, and the control group of BUN(15.32±2.62)μmol/L, Scr(253.84±55.12)μmol/L were lower after the treatment, being significant(t=5.182, 9.359, P<0.05). Conclusion The clinical efficacy of citrate anticoagulation in the treatment of acute renal injury with sepsis is superior to the systemic heparinized anticoagulant effect, which is helpful for the improvement of renal function and the prolongation of filter use time.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.22.41.47